Leibniz Institute for Immunotherapy is an educational organization that offers research in target structures, cell production, and therapy.
Leibniz Institute for Immunotherapy has raised $2.8M in total funding. The most recent round was Grant. The last funding was announced in May 2024.
Leibniz Institute for Immunotherapy is headquartered in Regensburg, Germany.
Leibniz Institute for Immunotherapy is an educational organization that offers research in target structures, cell production, and therapy.
Leibniz Institute for Immunotherapy is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Leibniz Institute for Immunotherapy — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/leibniz-institute-for-immunotherapy. Accessed September 30, 2026.
VCBacked. (2024). Leibniz Institute for Immunotherapy — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/leibniz-institute-for-immunotherapy
{{cite web |title=Leibniz Institute for Immunotherapy — Funding & Investors |url=https://www.vcbacked.co/company/leibniz-institute-for-immunotherapy |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated